RTD Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
MSV
VWM
SIS
QPBE
FFA
RT
WF
AAA
ACM
RTD Financial Advisors's PFE Position: Q3 2026 in Review
RTD Financial Advisors reduced its Pfizer (PFE) stake by 0.48% in Q3 2026, selling an estimated $7.5K and leaving 58,168 shares worth $1.66M. The position accounts for 0.18% of the portfolio, ranked #65.
RTD Financial Advisors first reported a position in PFE in Q4 2021 and has held it in 20 quarters since. The position peaked at $3.75M in Q4 2021. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- RTD Financial Advisors held 58,168 shares of Pfizer worth $1.66M as of Q3 2026.
- RTD Financial Advisors sold 282 Pfizer shares in Q3 2026, an estimated $7.5K.
- Pfizer made up 0.18% of RTD Financial Advisors's portfolio in Q3 2026, its #65 holding.
- RTD Financial Advisors first reported a position in Pfizer in Q4 2021 and has held it in 20 quarters since.
- RTD Financial Advisors's Pfizer position peaked at $3.75M in Q4 2021.
- 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on RTD Financial Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.